Armada shareholders vote on $1B Evernorth Nasdaq listing September 30
AI models flag the coming week as a key event window for XRP: a shareholder vote on taking the first XRP-focused holding company public on Nasdaq coincides with a tightly defined technical range. The SEC sued Ripple six years ago arguing XRP was a security. On September 30, Armada Acquisition Corp. II shareholders vote on a merger that would list Evernorth on Nasdaq under the ticker XRPN.
XRP trades near $1.4866, down 2% on the day. Price remains rangebound between a consistent ceiling and support floor.
What Evernorth Is
Evernorth is an XRP treasury company that actively deploys holdings across the ecosystem: yield strategies, infrastructure participation, and capital markets activity. It holds about 473 million XRP, making it a major identifiable corporate holder. The company has secured over $1 billion in gross proceeds and has $30 million in convertible senior notes due 2031 lined up, contingent on merger approval. Backers include Ripple, SBI Holdings, Pantera Capital, Kraken, and Arrington Capital.
Nasdaq Listing Implications
A listing would provide XRP exposure via equity, enabling participation by institutions restricted from direct crypto ownership and retail investors using brokerage accounts. Symbolically, the SEC would be processing paperwork for an XRP treasury company to list on a major U.S. exchange while having previously argued XRP was an unregistered security.
A vote does not equal a listing, and a listing does not create automatic buying pressure. Evernorth already owns its 473 million XRP. The listing would create a transparent institutional holder with a public balance sheet and incentives to accumulate over time.
AI-Flagged XRP Levels and Setup
XRPUSDT Chart 1D TradingView
XRP bottomed near $1.00 in August and recovered into a tight range. The 50-day EMA at $1.3690 has crossed above the 200-day EMA at $1.3612, both just above prior support at $1.2720.
- Range ceiling: $1.6227. A daily close above signals an upside break.
- Primary support: $1.3612 to $1.3690. Converged 50/200-day EMAs that have supported pullbacks.
- Final support: $1.2720. A loss would negate the August recovery.
Scenario path: Approval on September 30 likely prompts a test of $1.6227, with clearance opening a path toward $1.80. Rejection or delay increases the probability of a move back to the EMA zone around $1.36. The compressed $1.36 to $1.62 range implies elevated volatility on resolution.
Note: Content includes references to external market intelligence links and social posts. Promotional calls-to-action have been removed.







